Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00199836
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:57.411301+00:00
Published At
2021-07-15T00:00:00+00:00
Record Updated At
2022-10-10
Results Posted At
2021-07-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer", "Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-10-10"
protocolSection.identificationModule.nctId
"NCT00199836"
protocolSection.identificationModule.officialTitle
"A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide\u00ae ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-07-15"

Study condition terms

  • Cancer (protocolSection.conditionsModule.conditions)
  • Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.